Biocon Biologics integrates Vitaris’ biosimilars business

NEW DELHI : Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd, on Monday announced a…

ABB stock had a stellar run, but there may be speed breakers ahead

ABB India Ltd’s shares have been on a roll, appreciating by a whopping 68% so far…

Biocon Q2 Results: Revenue recorded at Rs 2384 cr, a growth of 26%

New Delhi Bengaluru-based bio-pharma company Biocon Biologics on Monday announced its consolidated financial results for the…

Pharma companies may see marginal earnings due to higher cost and base effect

New Delhi : Indian drug makers have lately seen the sentiments subdued. Companies reported a decline…

Biocon arm to acquire Vytris’ biosimilar assets for $3.33 billion

biopharmaceutical company Biocon announced on Monday that the board of directors of Biocon Biologics Ltd., a…

India’s vaccine industry may grow from $2 billion to $5 billion by 2026: Report

New Delhi As new Indian and global pharmaceutical companies add vaccines as a significant part of…